ARCT Q3 2019 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$210M

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-3.1% YoY

Gross Profit

-$4M-112.6% margin

Operating Income

-$8M-229.5% margin

Net Income

-$7M-224.0% margin

EPS (Diluted)

$-0.56

QoQ Revenue Growth

-67.3%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$383,000

Balance Sheet

Total Assets

$87M

Total Liabilities

$51M

Stockholders' Equity

$36M

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	-3.1%
Gross Profit	-$4M	-$546,000	-584.1%
Operating Income	-$8M	-$4M	-74.8%
Net Income	-$7M	-$4M	-74.8%